Conclusions: NEL revascularization of chronic mesenteric ischemia has a higher mortality, longer length of stay, and associated health care costs as well as higher rate of bowel resection. Mortality for both NEL and EL revascularizations has reduced over time. The rate of mortality has decreased more dramatically for EL revascularization. These findings may point to benefit from EL revascularization for CMI, but longitudinal studies are needed to see if this benefit extends beyond the index hospitalization.
, and mean weight loss at presentation was 20.3 6 36.2 pounds. The mean time from symptoms to diagnosis was 28.3 6 30.1 months. Diagnostic imaging used prior to referral to us most commonly involved mesenteric ultrasound (16%), magnetic resonance angiography (4%), angiography (8%), and nondynamic CTA (64%). The mean degree of celiac artery stenosis on dynamic CTA was 73.7% 6 23.8%. Seventeen patients (68%) had celiac plexus block prior to definitive intervention. No in-hospital morbidity or mortality occurred in this cohort. Follow-up data were available for all patients for a median of 4.3 months (range, 1-90 months). The freedom from symptoms was 92%, and freedom from reintervention was 100%. All patients reported excellent or good response to surgery with improvements in their quality of life and weight gain.
Conclusions: An institutional protocol of dynamic CTA has greatly expedited diagnosis and treatment plans for patients with suspected MALS. In this longitudinal evaluation, celiac decompression, with or without bypass, was associated with symptomatic relief and improvements in quality of life. Further prospective evaluation of these results is warranted. Objectives: Venous duplex ultrasound (VDU) imaging is often the sole imaging modality used to diagnose deep vein thrombosis and guide critical clinical decision making. However, VDU imaging is highly user dependent, with considerable inter-and intra-sonographer variation, making quality assurance (QA) imperative. We hypothesized that a standardized audit-feedback-education QA cycle, based on objective scoring criteria, reduces variation as measured by compliance with a written VDU protocol. Our goal was to achieve at least 90% VDU protocol compliance at the laboratory and sonographer levels.
Methods: At the UMass Memorial Health Care vascular laboratory, we implemented a standardized audit-feedback-education QA cycle that addressed four domains: minimum views, documentation, image optimization, and scanning time. Each domain was scored according to predefined objective criteria and then weighted in order to calculate a protocol compliance index (PCI) for each sonographer. At baseline, three VDUs per sonographer were scored. After implementation, three to five VDUs per sonographer were scored at 1 month, then at 15, 27, 38, 52, and 65 months (Table) . Each standardized audit-feedback-education QA cycle included structured 1-hour sessions between the lead technologist and each sonographer to review scores and protocol deviations. Baseline and postimplementation scores were compared at the laboratory and sonographer levels.
Results: Between December 2010 and May 2016, 31 sonographers and 442 VDUs were reviewed. At the laboratory level, baseline mean scores were minimum views, 85%; documentation, 98%; image optimization, 88%; and scanning time, 88%; yielding a mean PCI of 90%. At 1 month, mean scores did not change significantly. By 15 months, improvements were observed: minimum views, 94% (Fig) ; documentation, 98%; image optimization, 93%; scanning time, 116%; yielding a mean PCI of 96%. At Objectives: This study was conducted to determine the prevalence of vascular disease in an asymptomatic patient population and to provide education on vascular disease and risk factor modification.
Methods: We offered free vascular disease screening using carotid duplex, aortic duplex, and ankle-brachial index (ABI) for our local urban community. The screening was offered to all asymptomatic patients at least 50 years of age with at least one risk factor of vascular disease. We report the outcomes of these studies as mild, moderate, or severe. A description of our findings with analysis of the patient risk factors will be presented.
Results: A total of 4206 patients (1457 males, 2749 females) were screened, and the mean age was 71.87. Of these, 230 had moderate to severe disease in at least one of the three study territories, and 2108 patients had evidence of mild disease. A total of 57% of our patients were $70 years, 52% were smokers, 0.1% were dialysis dependent, 66% had hyperlipidemia, 11% had coronary artery disease, 57% had hypertension, and 40% had a body mass index >30. There were 48 abdominal aortic aneurysms diagnosed with five >5 cm and 43 were 3 to 5 cm. Of those found with carotid stenosis, 16 were severe, 110 were moderate, and 2054 had mild disease.
Conclusions: Findings of this screening program suggest additional public awareness might be prudent. Educational programs on what constitutes vascular disease and risk factor modification should be considered.
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Hypertrophy of the Anterior Scalene Muscle As the Culprit of Arterial Thoracic Outlet Syndrome Erion Qaja, Robert Rhee, Sara Honari. Maimonides Medical Center, Brooklyn, NY Objectives: Thoracic outlet syndrome (TOS) was first introduced by Peet et al in 1956. Since then it has been studied extensively and subcategorized into at least four related syndromes: neurogenic TOS due to compression of brachial plexus, arterial TOS in cases of compression of subclavian artery, venous TOS due to compression of subclavian vein, and nonspecific type of TOS with unclear etiology. Presence of cervical ribs, first rib anomalies, clavicle nonunions, cervical muscle hypertrophy, repetitive motion, and posture issues are list of the etiologies that have been described in resulting in compressive symptoms. Arterial TOS comprises about 1% of all TOS cases. Here we describe arterial TOS caused by hypertrophy of the anterior scalene muscle in a 65-yearold man. 
